This is an original summary of publicly available health commentary and cited research. It is health news and commentary for SupportFreedom readers—not medical advice, a diagnosis, or a treatment plan. Category framing: Health → DMSO. Consult a licensed clinician before changing care.

The anecdote

Murray, 75 and blind since birth in one narrative, used DMSO for sinus relief that arrived quickly; continued use was followed by color perception, finger counting, and progressive acuity gains he called unbelievable.

Broader eye framing

VF amplifies AMD’s ophthalmology report: German clinic lore, macular/cataract/uveitis testimonials, retinitis pigmentosa snippets, and microcirculation/protein-stabilization hypotheses.

Regulatory turn

Piece argues 1960s suppression was about control of an unpatentable multi-use solvent, not proven blindness risk—despite FDA’s historical caution messaging.

SupportFreedom stance

Extraordinary N=1 plus secondary synthesis. Homemade eye drops carry infection risk; ophthalmology care stays primary.

For SupportFreedom readers, separate three layers carefully: (1) laboratory and historical clinical literature, (2) curated patient testimonials, and (3) regulatory or commercial incentives that shape guidelines. DMSO coverage often mixes all three—newsworthy, and why cautious language matters.

Practical hygiene themes recur across careful DMSO writing: pharmaceutical-grade purity claims, clean skin before topical use, awareness that the solvent can carry other chemicals inward, and respect for drug-interaction potential. Those points remain relevant whether a source is enthusiastic or skeptical.

Nothing in this paraphrase replaces emergency care for stroke, spinal injury, acute vision loss, severe infection, or suspected cancer. Established clinicians, imaging when indicated, and open discussion of evidence quality still come first. Health → DMSO posts inform civic and personal curiosity about neglected therapies without turning commentary into a protocol.

Editors should note publication date, paywall status, and whether claims cite primary papers versus secondary Substack synthesis. This draft is tuned for WordPress readability while remaining an original paraphrase for SupportFreedom.

For SupportFreedom readers, separate three layers carefully: (1) laboratory and historical clinical literature, (2) curated patient testimonials, and (3) regulatory or commercial incentives that shape guidelines. DMSO coverage often mixes all three—newsworthy, and why cautious language matters.

Practical hygiene themes recur across careful DMSO writing: pharmaceutical-grade purity claims, clean skin before topical use, awareness that the solvent can carry other chemicals inward, and respect for drug-interaction potential. Those points remain relevant whether a source is enthusiastic or skeptical.

Source

Original article: 75-Year-Old Blind Man Uses DMSO to Treat Sinusitis — The Vigilant Fox.